UK firm Native Antigen launches 10 new MABs reagents for COVID-19 detection kits
Ten new monoclonal antibodies recognize distinct Spike protein epitopes on SARS-CoV-2 and the antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein. Different epitopes support identification of matched-pair reagents for immunoassay development
Students from UP, Finland win first Biotech Online poster competition organized by Karnataka Government
The Biotech Online poster presentation organized jointly by K-Tech, Association of Biotechnology Led Enterprises (ABLE) and media platform, Biotecnika and Stempeutics, was done completely online in the last week of September.
Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
ABLE Member and Hyderabad-headquartered pharma major Aurobindo Pharma announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine.
“Biological E can make a billion doses of the vaccine a year,” Dr Maria Elena Bottazzi, associate dean, BCM National School of Tropical Medicine
In an interview to The Indian Express, Dr Maria Elena Bottazzi, said that Hyderabad-headquartered vaccine maker Biological E can help scale up production of an affordable Covid-19 vaccine.